Chloroquine, a FDA-approved Drug, Prevents Zika Virus Infection and its Associated Congenital Microcephaly in Mice

JOURNAL ARTICLE published October 2017 in EBioMedicine

Research funded by MOST (2016YFD0500304) | State Key Laboratory of Pathogen and Biosecurity (SKLPBS1601) | NSFC Excellent Young Scientist (81522025) | Innovative Research Group (81621005) | UK Academy of Medical Sciences (81661130162) | CAMS Initiative for Innovative Medicine (2016-I2M-1-005) | NSFC (91542201,81590765) | NIH (R01 AI069120,AI056154,AI078389 502) | NSFC of China (31670883) | PUMC Youth Fund (3332016125) | NSFC (31500145) | NSFC (31430037) | STCSM (16JC1420500) | Beijing Brain Project (Z161100002616004) | MOST (2014CB942801,2012YQ03026006) | National Science and Technology Major Project (2015ZX09102023)

Authors: Chunfeng Li | Xingliang Zhu | Xue Ji | Natalie Quanquin | Yong-Qiang Deng | Min Tian | Roghiyh Aliyari | Xiangyang Zuo | Ling Yuan | Shabbir Khan Afridi | Xiao-Feng Li | Jae U. Jung | Karin Nielsen-Saines | Frank Xiao-Feng Qin | Cheng-Feng Qin | Zhiheng Xu | Genhong Cheng